NASD
| Health Care |
Biotechnology
Genmab A/S (GMAB)
LAST (2 Apr, 12:21 PM ET)
Extended HOURS (00:00 PM ET)
MARKET CAP
VOLUME
| Open | 18.48 |
| Previous Close | 18.66 |
| Day Range | 18.48 - 18.75 |
| 52-Week Range | 18.62 - 30.50 |
| All-Time High | 49.07 |
| Avg. Volume (50-day) | 1,561,283.5 |
| EPS (TTM) | 1.77 |
| Next Earnings Date | 2025-05-08 |
| Last Earnings Date | 2025-02-12 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | Yes |
| P/E Ratio | 10.54 |
| PEG Ratio | 0.28 |
| Price to Book | 2.33 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | 3.12 B |
| Revenue per Share (TTM) | 4.88 |
| Shares Outstanding | 635.502 M |
| Share Float (%) | 635.50 M |
| % Held by Institutions | 9.61 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 20.1 (-6.77%) |
| +/- SMA(50) | 20.75 (-9.69%) |
| +/- SMA(200) | 23.35 (-19.74%) |
| 5-Day Perf. | -4.49% |
| 1-Month Perf. | -17.37% |
| 3-Month Perf. | -10.76% |
| 6-Month Perf. | -20.89% |
| YTD Perf. | -10.21% |
| 1-Year Perf. | -37.45% |
| RSI(14) | 35.95 |
| ATR(14) | 0.65 |
| ADX(14) | 23.1 |
| Beta (5Y) | 0.74 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
GMAB
Genmab A/S
Sector: Health Care
Industry: Biotechnology
Employees: 2,682
Description
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.
GMAB has triggered the following predefined scans:
| P&F Double Bottom Breakdown |
| P&F Descending Triple Bottom Breakdown |
| New 52-week Lows |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
